Sana Biotechnology logo

Sana Biotechnology Share Price Today

(NASDAQ: SANA)

Sana Biotechnology share price is $2.55 & ₹221.77 as on 6 Mar 2025, 2.30 'hrs' IST

$2.55

-0.01

(-0.39%)

Market is closed - opens 8 PM, 06 Mar 2025

View live Sana Biotechnology share price in Dollar and Rupees. Guide to invest in Sana Biotechnology stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Sana Biotechnology, along with analyst recommendations, forecasts, and comprehensive financials.

Sana Biotechnology share price movements

  • Today's Low: $2.51
    Today's High: $2.66

    Day's Volatility :5.64%

  • 52 Weeks Low: $1.52
    52 Weeks High: $10.50

    52 Weeks Volatility :85.52%

Sana Biotechnology (SANA) Returns

PeriodSana Biotechnology IncSector (Health Care)Index (Russel 2000)
3 Months
11.11%
3.7%
0.0%
6 Months
-52.87%
-2.8%
0.0%
1 Year
-73.79%
2.5%
0.0%
3 Years
-51.34%
12.9%
-11.6%

Sana Biotechnology (SANA) Key Statistics

in dollars & INR

Previous Close
$2.56
Open
$2.61
Today's High
$2.66
Today's Low
$2.51
Market Capitalization
$571.6M
Today's Volume
$2.5M
52 Week High
$10.5
52 Week Low
$1.52
Revenue TTM
$0.0
EBITDA
$-273.8M
Earnings Per Share (EPS)
$-1.48
Profit Margin
0.0%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-92.9%

How to invest in Sana Biotechnology Stock (SANA) from India?

It is very easy for Indian residents to invest directly in Sana Biotechnology from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Sana Biotechnology stock in both Indian Rupees (INR) and US Dollars (USD). Search for Sana Biotechnology or SANA on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Sana Biotechnology or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Sana Biotechnology shares which would translate to 0.341 fractional shares of Sana Biotechnology as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Sana Biotechnology, in just a few clicks!

Returns in Sana Biotechnology (SANA) for Indian investors in Rupees

The Sana Biotechnology stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Sana Biotechnology investment value today

Current value as on today

₹31,156

Returns

₹68,844

(-68.84%)

Returns from Sana Biotechnology Stock

₹73,792 (-73.79%)

Dollar Returns

₹4,949 (+4.95%)

Indian investors sentiment towards Sana Biotechnology (SANA)

-80%

Period: Feb 3, 2025 to Mar 5, 2025. Change in 30 Days versus previous period

Search interest for Sana Biotechnology Stock from India on INDmoney has decreased by -80% in the last 30 days, reflecting a downward trend in search activity.

Global Institutional Holdings in Sana Biotechnology

  • FMR Inc

    15.00%

  • Flagship Ventures Management, Inc.

    11.20%

  • BlackRock Inc

    5.34%

  • Vanguard Group Inc

    4.81%

  • Baillie Gifford & Co Limited.

    4.58%

  • Canada Pension Plan Investment Board

    4.56%

Analyst Recommendation on Sana Biotechnology

Buy

    76%Buy

    23%Hold

    0%Sell

Based on 13 Wall street analysts offering stock ratings for Sana Biotechnology(by analysts ranked 0 to 5 stars)

Based on 13 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
10
10
10
Hold
3
3
3
Sell
0
0
0

Analyst Forecast on Sana Biotechnology Stock (SANA)

What analysts predicted

Upside of 284.31%

Target:

$9.80

Current:

$2.55

Insights on Sana Biotechnology Stock (Ticker Symbol: SANA)

  • Price Movement

    In the last 6 months, SANA stock has moved down by -49.4%
  • SANA vs ALNY (1 yr)

    In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 66.5% return, outperforming this stock by 140.3%
  • SANA vs VRTX (3 yr)

    In the last 3 years, Vertex Pharmaceuticals Incorporated has given 51.6% return, outperforming this stock by 104.4%

Sana Biotechnology Technicals Summary

Sell

Neutral

Buy

Sana Biotechnology is currently in a neutral trading position according to technical analysis indicators.

Sana Biotechnology (SANA) Vs Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Sana Biotechnology Inc logo
-19.56%
-52.87%
-73.79%
-51.34%
-87.93%
Regeneron Pharmaceuticals, Inc. logo
-1.42%
-40.28%
-29.31%
11.08%
44.83%
Beone Medicines Ltd logo
17.63%
36.87%
64.37%
45.89%
71.3%
Vertex Pharmaceuticals Incorporated logo
1.94%
4.92%
19.37%
108.73%
123.83%
Alnylam Pharmaceuticals, Inc. logo
-8.03%
-0.89%
66.53%
52.9%
126.66%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Sana Biotechnology Inc logo
NA
NA
NA
-1.14
-0.93
-0.31
NA
1.31
Regeneron Pharmaceuticals, Inc. logo
17.86
17.86
1.01
43.09
0.16
0.07
0.01
273.57
Beone Medicines Ltd logo
NA
NA
NA
1.43
-0.19
-0.06
NA
31.22
Vertex Pharmaceuticals Incorporated logo
32.84
NA
1.34
18.07
-0.03
0.13
NA
63.87
Alnylam Pharmaceuticals, Inc. logo
NA
NA
-0.49
0.57
-15.01
-0.03
NA
0.52
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Sana Biotechnology Inc logo
Buy
$571.6M
-87.93%
NA
0.0%
Regeneron Pharmaceuticals, Inc. logo
Buy
$73.8B
44.83%
17.86
31.07%
Beone Medicines Ltd logo
NA
$29.1B
71.3%
NA
-16.92%
Vertex Pharmaceuticals Incorporated logo
Buy
$124.9B
123.83%
32.84
-4.86%
Alnylam Pharmaceuticals, Inc. logo
Buy
$31.4B
126.66%
NA
-12.37%

About Sana Biotechnology

Sana Biotechnology, Inc., a biotechnology company, focuses on utilizing engineered cells as medicines. It develops ex vivo and in vivo cell engineering platforms for various therapeutic areas with unmet treatment needs, including oncology, diabetes, central nervous system disorders, B-cell-mediated autoimmune, and others. The company's product candidates include SC291 that is used as allogeneic cell therapies for hematologic malignancies; ARDENT for a potential treatment for non-Hodgkin's lymphoma, and chronic lymphoblastic leukemia; GLEAM, to treat multiple autoimmune disorders that involve production of autoimmune antibodies, including lupus nephritis, extrarenal lupus, antineutrophil cytoplasmic antibody -associated vasculitis, and others. It is developing SC262 to treat patients with relapsed and/or refractory B-cell malignancies; SC255 for multiple myeloma treatment; SC379, a therapy for patients with certain central nervous system disorders healthy allogeneic glial progenitor cells; SC451, a product candidate to treat diabetes, with an initial focus on type 1 diabetes mellitus; and UP421 that reduces long-term exogenous insulin dependence. The company has an option and license agreement with Beam Therapeutics Inc. for use of Beam's proprietary CRISPR Cas12b nuclease editing technology to research, develop, and commercialize engineered cell therapy products; and a license agreement with Harvard College to access certain intellectual property for the development of hypoimmune-modified cells. The company was formerly known as FD Therapeutics, Inc. and changed its name to Sana Biotechnology, Inc. in September 2018. Sana Biotechnology, Inc. was incorporated in 2018 and is headquartered in Seattle, Washington.
Organization
Sana Biotechnology
Employees
328
CEO
Dr. Steven D. Harr M.D.
Industry
Services

Management People of Sana Biotechnology

NameTitle
Dr. Steven D. Harr M.D.
President, CEO & Director
Ms. Susan Wyrick
Acting CFO, Treasurer, Principal Accounting Officer and Senior VP of Finance & Accounting
Mr. Snehal Patel
Senior VP & Chief Technical Officer
Dr. Dhavalkumar D. Patel M.D., Ph.D.
Executive VP & Chief Scientific Officer
Mr. Bernard J. Cassidy J.D.
Executive VP, General Counsel & Corporate Secretary
Dr. Sonja Schrepfer M.D., Ph.D.
Senior VP & Head of Hypoimmune Platform
Dr. Gary Meininger M.D.
Chief Medical Officer
Dr. Yuko Soneoka J.D., Ph.D.
Head of Intellectual Property
Mr. John Gerecitano M.D., Ph.D.
Head of Oncology Research & Development

Important FAQs about investing in SANA Stock from India :

What is Sana Biotechnology share price today?

Sana Biotechnology share price today stands at $2.55, Open: $2.61 ; Previous Close: $2.56 ; High: $2.66 ; Low: $2.51 ; 52 Week High: $10.50 ; 52 Week Low: $1.52.

The stock opens at $2.61, after a previous close of $2.56. The stock reached a daily high of $2.66 and a low of $2.51, with a 52-week high of $10.50 and a 52-week low of $1.52.

Can Indians buy Sana Biotechnology shares?

Yes, Indians can invest in the Sana Biotechnology (SANA) from India.

With INDmoney, you can buy Sana Biotechnology at 0 brokerage. The step-by-step process is as follows:

  • Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
  • Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
  • Once funds are transferred successfully, you can buy Sana Biotechnology at zero transaction cost.

How can I buy Sana Biotechnology shares from India?

It is very easy to buy Sana Biotechnology from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Sana Biotechnology (SANA) be purchased?

Yes, you can buy fractional shares of Sana Biotechnology with INDmoney app.

What are the documents required to start investing in Sana Biotechnology stocks?

To start investing in Sana Biotechnology, You will need the following documents:

  • Proof of Identification (PAN, Aadhaar etc)
  • Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

What are today’s High and Low prices of Sana Biotechnology Stock (SANA)?

Today’s highest price of Sana Biotechnology (SANA) is $2.66.

Today’s lowest price of Sana Biotechnology (SANA) is $2.51.

What is today's market capitalisation of Sana Biotechnology?

Today's market capitalisation of Sana Biotechnology SANA is 571.6M

What is the 52 Week High and Low Range of Sana Biotechnology Stock (SANA)?

  • 52 Week High

    $10.50

  • 52 Week Low

    $1.52

What are the historical returns of Sana Biotechnology (SANA)?

  • 1 Month Returns

    -19.56%

  • 3 Months Returns

    -52.87%

  • 1 Year Returns

    -73.79%

  • 5 Years Returns

    -87.93%

Who is the Chief Executive Officer (CEO) of Sana Biotechnology ?

Dr. Steven D. Harr M.D. is the current Chief Executive Officer (CEO) of Sana Biotechnology.